insights_auto
Why is ORX down 3,58%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
0,84 SEK
arrow_downward
-3,58%(-0,031) 1D
13 қар., 14:46:32 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
291,96 млн
Avg. vol.
739,90 м.
Volume
665,41 м.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
0,90 SEK
High
0,90 SEK
Low
0,83 SEK
Mkt. cap
291,96 млн
Avg. vol.
739,90 м.
Volume
665,41 м.
P/E ratio
0,06
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
Trefis
·
1 сағат бұрын
Nvidia Is 6.1% Of Your S&P 500 Fund. What Is Your Number?
Investing.com
·
1 сағат бұрын
Goldman’s Oppenheimer sees S&P 500 advancing to 8,700 in 2027
Yahoo Finance
·
32 минут бұрын
The S&P 500 Recently Experienced Its Worst Day Since 2025. Here's Why Investors Shouldn't Worry.
FOREX.com
·
1 сағат бұрын
S&P 500 forecast: SPX struggles for direction ahead of PPI data
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com